HSP90AB1 and cancer: Such a re-shaping of HSP90 inhibition, aimed at avoiding the deleterious effects of a global damage to cellular proteostasis, would imply selecting different agents for combination usage and reconsidering dosing strategies, adapting them to various cancer patient subsets (173).